This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by He, Y.
Right arrow Articles by Katze, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by He, Y.
Right arrow Articles by Katze, M. G.

 Previous Article  |  Next Article 

Journal of Virology, June 2001, p. 5090-5098, Vol. 75, No. 11
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.11.5090-5098.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Regulation of mRNA Translation and Cellular Signaling by Hepatitis C Virus Nonstructural Protein NS5A

Yupeng He,1 Seng-Lai Tan,1,dagger Semih U. Tareen,2 Sangeetha Vijaysri,3 Jeffrey O. Langland,3 Bertram L. Jacobs,3,4 and Michael G. Katze1,2,*

Department of Microbiology, School of Medicine,1 and Regional Primate Research Center,2 University of Washington, Seattle, Washington 98195, and Department of Microbiology3 and Graduate Degree Program in Molecular and Cellular Biology,4 Arizona State University, Tempe, Arizona 85287

Received 8 December 2000/Accepted 2 March 2001

The NS5A nonstructural protein of hepatitis C virus (HCV) has been shown to inhibit the cellular interferon (IFN)-induced protein kinase R (PKR). PKR mediates the host IFN-induced antiviral response at least in part by inhibiting mRNA translation initiation through phosphorylation of the alpha  subunit of eukaryotic initiation factor 2 (eIF2alpha ). We thus examined the effect of NS5A inhibition of PKR on mRNA translation within the context of virus infection by using a recombinant vaccinia virus (VV)-based assay. The VV E3L protein is a potent inhibitor of PKR. Accordingly, infection of IFN-pretreated HeLa S3 cells with an E3L-deficient VV (VVDelta E3L) resulted in increased phosphorylation levels of both PKR and eIF2alpha . IFN-pretreated cells infected with VV in which the E3L locus was replaced with the NS5A gene (VVNS5A) displayed diminished phosphorylation of PKR and eIF2alpha in a transient manner. We also observed an increase in activation of p38 mitogen-activated protein kinase in IFN-pretreated cells infected with VVDelta E3L, consistent with reports that p38 lies downstream of the PKR pathway. Furthermore, these cells exhibited increased phosphorylation of the cap-binding initiation factor 4E (eIF4E), which is downstream of the p38 pathway. Importantly, these effects were reduced in cells infected with VVNS5A. NS5A was also found to inhibit activation of the p38-eIF4E pathway in epidermal growth factor-treated cells stably expressing NS5A. NS5A-induced inhibition of eIF2alpha and eIF4E phosphorylation may exert counteracting effects on mRNA translation. Indeed, IFN-pretreated cells infected with VVNS5A exhibited a partial and transient restoration of cellular and viral mRNA translation compared with IFN-pretreated cells infected with VVDelta E3L. Taken together, these results support the role of NS5A as a PKR inhibitor and suggest a potential mechanism by which HCV might maintain global mRNA translation rate during early virus infection while favoring cap-independent translation of HCV mRNA during late infection.

* Corresponding author. Mailing address: Department of Microbiology, Box 358070, University of Washington, Seattle, WA 98195. Phone: (206) 732-6135. Fax: (206) 732-6055. E-mail: honey{at}u.washington.edu.

dagger Present address: Infectious Diseases Research, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285.

Journal of Virology, June 2001, p. 5090-5098, Vol. 75, No. 11
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.11.5090-5098.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Boudreau, H. E., Emerson, S. U., Korzeniowska, A., Jendrysik, M. A., Leto, T. L. (2009). Hepatitis C Virus (HCV) Proteins Induce NADPH Oxidase 4 Expression in a Transforming Growth Factor {beta}-Dependent Manner: a New Contributor to HCV-Induced Oxidative Stress. J. Virol. 83: 12934-12946 [Abstract] [Full Text]  
  • Wu, S.-C., Chang, S. C., Wu, H.-Y., Liao, P.-J., Chang, M.-F. (2008). Hepatitis C Virus NS5A Protein Down-regulates the Expression of Spindle Gene Aspm through PKR-p38 Signaling Pathway. J. Biol. Chem. 283: 29396-29404 [Abstract] [Full Text]  
  • Ye, Y., Hauns, K., Langland, J. O., Jacobs, B. L., Hogue, B. G. (2007). Mouse Hepatitis Coronavirus A59 Nucleocapsid Protein Is a Type I Interferon Antagonist. J. Virol. 81: 2554-2563 [Abstract] [Full Text]  
  • Wohnsland, A., Hofmann, W. P., Sarrazin, C. (2007). Viral Determinants of Resistance to Treatment in Patients with Hepatitis C. Clin. Microbiol. Rev. 20: 23-38 [Abstract] [Full Text]  
  • Macdonald, A., Harris, M. (2004). Hepatitis C virus NS5A: tales of a promiscuous protein. J. Gen. Virol. 85: 2485-2502 [Abstract] [Full Text]  
  • Macdonald, A., Crowder, K., Street, A., McCormick, C., Saksela, K., Harris, M. (2003). The Hepatitis C Virus Non-structural NS5A Protein Inhibits Activating Protein-1 Function by Perturbing Ras-ERK Pathway Signaling. J. Biol. Chem. 278: 17775-17784 [Abstract] [Full Text]  
  • Wang, C., Pflugheber, J., Sumpter, R. Jr., Sodora, D. L., Hui, D., Sen, G. C., Gale, M. Jr. (2003). Alpha Interferon Induces Distinct Translational Control Programs To Suppress Hepatitis C Virus RNA Replication. J. Virol. 77: 3898-3912 [Abstract] [Full Text]  
  • He, Y., Yan, W., Coito, C., Li, Y., Gale, M. Jr, Katze, M. G. (2003). The regulation of hepatitis C virus (HCV) internal ribosome-entry site-mediated translation by HCV replicons and nonstructural proteins. J. Gen. Virol. 84: 535-543 [Abstract] [Full Text]  
  • He, Y., Nakao, H., Tan, S.-L., Polyak, S. J., Neddermann, P., Vijaysri, S., Jacobs, B. L., Katze, M. G. (2002). Subversion of Cell Signaling Pathways by Hepatitis C Virus Nonstructural 5A Protein via Interaction with Grb2 and P85 Phosphatidylinositol 3-Kinase. J. Virol. 76: 9207-9217 [Abstract] [Full Text]  
  • Banerjee, S., Narayanan, K., Mizutani, T., Makino, S. (2002). Murine Coronavirus Replication-Induced p38 Mitogen-Activated Protein Kinase Activation Promotes Interleukin-6 Production and Virus Replication in Cultured Cells. J. Virol. 76: 5937-5948 [Abstract] [Full Text]  
  • Child, S. J., Jarrahian, S., Harper, V. M., Geballe, A. P. (2002). Complementation of Vaccinia Virus Lacking the Double-Stranded RNA-Binding Protein Gene E3L by Human Cytomegalovirus. J. Virol. 76: 4912-4918 [Abstract] [Full Text]  
  • Guidotti, L. G., Morris, A., Mendez, H., Koch, R., Silverman, R. H., Williams, B. R. G., Chisari, F. V. (2002). Interferon-Regulated Pathways That Control Hepatitis B Virus Replication in Transgenic Mice. J. Virol. 76: 2617-2621 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»